Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Study confirms predictability of microkeratome
London-Results of a study evaluating a recently released microkeratome (Zyoptix XP, Bausch & Lomb) indicate it is a reliable instrument for predictable flap creation, reported Jay S. Pepose, MD, PhD, at the XXIV Congress of the European Society of Cataract and Refractive Surgeons.
Related Videos
Related Content
